structural and functional coronary artery abnormalities in

Circulation Journal Vol.79, July 2015

Circulation JournalOfficial Journal of the Japanese Circulation Societyhttp://www.j-circ.or.jp

angina. This may lead to identification of therapeutic targets in the future. The aim of this article is to review the structural and functional coronary artery abnormalities in patients with vasospastic angina.

Definition and Pathophysiology of Coronary Artery Spasm

According to the Guidelines of the Japanese Circulation Soci-ety,6 coronary spasm is defined as a transient constriction of an epicardial coronary artery >90%, leading to resting angina (and/or dyspnea) and ischemic ECG changes (Figure 1). However, spasm can also occur at the level of the coronary microcirculation, with reproduction of symptoms and isch-emic ECG changes but without epicardial spasm (Figure 2),7 although this phenomenon cannot currently be directly visual-ized in humans in vivo. In some patients, spasm may even be present in the coronary epicardial arteries as well as in the microvessels.8 Anatomically, epicardial coronary spasm is defined as focal if it is confined within the borders of a coro-nary segment according to the 16 segment coronary model of the American Heart Association.9 Diffuse spasm is present if adjacent coronary segments are involved. Coronary spasm can occur in only one epicardial artery, but if several vessels may be involved, this is called multivessel spasm. Coronary spasm usually occurs spontaneously in an unpredictable fashion and usually leads to angina at rest but may also be asymptomatic

n 1959 Prinzmetal’s group was the first to describe patients with a variant form of angina (ie, angina at rest with transient ST-segment elevation and preserved exercise

capacity) and they suggested that the underlying cause was coronary artery spasm.1 However, they had no information about the in vivo coronary anatomy of their patients because the first coronary angiography had only been performed shortly before by Mason Sones in 1958. Autopsy in one of the patients described in Prinzmetal et al’s paper revealed that the right coronary artery (which presumably had caused resting angina with ST elevations in II, III and aVF) had an 80% stenosis. This observation led to the conclusion that coronary spasm was associated with atherosclerosis. Later, it was found that coro-nary spasm could also occur in patients with angiographically normal coronary arteries.2 It appeared that coronary spasm was a heterogeneous phenomenon that could occur in patients with or without coronary atherosclerosis. Moreover, it was seen that coronary spasm could be focal or diffuse, sometimes with changing patterns in the same patient.3 In addition, Mohri et al described coronary spasm of the microcirculation.4

Coronary spasm is involved in many clinical scenarios, such as stable angina, acute coronary syndrome, sudden cardiac death, non-ischemic cardiomyopathy, arrhythmia or syncope.5 In recent years, imaging tools such as computerized tomo-graphic angiography (CTA), intravascular ultrasound (IVUS) and optical coherence tomography (OCT) have been applied to study of the coronary pathology in patients with vasospastic

I

Received May 13, 2015; revised manuscript received May 28, 2015; accepted June 2, 2015; released online June 18, 2015Department of Cardiology, Robert Bosch Krankenhaus, Stuttgart (P.O., A. Aziz, A. Athanasiadis, U.S.), Germany; Department of Cardiol-

ogy, Odense University Hospital, Odense (A. Aziz, H.S.H.); and Department of Cardiology, Bispebjerg Hospital, University of Copenhagen, Copenhagen (E.P.), Denmark

Mailing address: Peter Ong, MD, Department of Cardiology, Robert-Bosch-Krankenhaus, Auerbachstraße 110, 70376 Stuttgart, Germany. E-mail: [email protected]

ISSN-1346-9843 doi: 10.1253/circj.CJ-15-0520All rights are reserved to the Japanese Circulation Society. For permissions, please e-mail: [email protected]

Structural and Functional Coronary Artery Abnormalities in Patients With Vasospastic Angina Pectoris

Peter Ong, MD; Ahmed Aziz, MD; Henrik Steen Hansen, MD; Eva Prescott, MD; Anastasios Athanasiadis, MD; Udo Sechtem, MD

Coronary spasm is involved in many clinical scenarios, such as stable angina, acute coronary syndrome, sudden cardiac death, non-ischemic cardiomyopathy, arrhythmia and syncope. In recent years, imaging tools such as com-puterized tomographic angiography, intravascular ultrasound or optical coherence tomography have been applied to study the coronary pathology in patients with vasospastic angina. Patients with vasospastic angina represent a heterogeneous cohort of patients with regard to the extent of concomitant coronary atherosclerosis. They share the common pathophysiological phenomenon of vascular smooth muscle hyperreactivity leading to spasm caused by various factors that may also overlap. Focal coronary spasm is related to epicardial atherosclerosis and in the pres-ence of obstructive coronary artery disease it may be useful to treat the lesion to prevent further spasm. The aim of this article is to review structural and functional coronary artery abnormalities in patients with vasospastic angina. (Circ J 2015; 79: 1431 – 1438)

Key Words: Atherosclerosis; Coronary artery disease; Vasospasm

REVIEW


1432 ONG P et al.

striction or vasodilation. In patients with vasospastic angina there is an abnormal vasoconstrictive response. Different pathogenic mechanisms have been proposed as the underlying cause. The most common are vascular smooth muscle cell (VSMC) hyperreactivity, endothelial dysfunction, low-grade inflammation and altered autonomic nervous system response, and these may in turn be modified by genetic factors.16

VSMC Hyperreactivity VSMC hyperreactivity is thought to be the main pathophysiological substrate for spasm17 and early studies of human coronary anatomy have shown that all coronary vessels, including the microvessels, have a similar wall structure that includes a layer of VSMCs.18 Animal stud-ies using light and electron microscopy have provided insights into the mechanics of VSMCs during spasm. They show that radial rearrangement of the medial VSMCs, because of their

(silent ischemia).10,11 However, various other clinical presenta-tions of patients with coronary spasm have been described, including but not limited to angina during exercise12 or syncope.13

The 2013 Guidelines by the European Society of Cardiol-ogy for Management of Stable Angina recommend perform-ing coronary angiography in patients with suspected coronary spasm to determine the underlying extent of coronary athero-sclerosis.14 Moreover, intracoronary provocation testing is recommended to determine the site and mode of spasm because it can be prognostically relevant.15

PathophysiologyCoronary arteries are able to adjust the blood supply to the heart during different loading conditions by either vasocon-

Figure 1. Severe multivessel epicardial spasm provoked by 100 μg intracoronary acetylcholine with reproduction of symptoms and marked ST-segment depression in a patient with recurrent angina at rest (Left). The changes resolved after intracoronary nitroglycerine injection (Right).

Figure 2. Coronary microvascular spasm in a female patient without relevant epicardial stenosis and without epicardial spasm during acetylcholine testing (ACH) but with ST-segment depression and reproduction of symptoms (Left). These changes resolved after nitroglycerine injection (Right). (Reproduced from Ong P, et al.7)


1433Structure and Function in Coronary Spasm

Oxidative Stress Oxidative stress (ie, increased produc-tion of oxygen-reactive species) may also contribute to the development of coronary spasm. It has been shown that bio-markers for oxidative stress (eg, thioredoxin) are elevated in patients with vasospastic angina21 compared with patients who have non-vasospastic angina. Moreover, concentrations of the antioxidant vitamin E are reduced in patients with vasospastic angina.22 In addition, cigarette smoking (a known risk factor for coronary spasm) has been identified as an important induc-tor of oxidative stress. Although there is still debate about whether oxidative stress is a direct cause of coronary spasm, because it is also present in various other vascular diseases, it can be regarded as a cofactor in the genesis of coronary spasm.

Low-Grade Inflammation Biomarkers of low-grade inflam-mation, such as high-sensitivity C-reactive protein, CD40 ligand and interleukin 6, have been shown to be elevated in patients with vasospastic angina compared with patients with non-vasospastic angina.23–25 Low-grade inflammation may cause upregulation of rho-kinase, leading to spasm.26 This may also explain the link between cigarette smoking and vasospastic angina, because cigarette smoking has also been shown to be associated with low-grade inflammation.27 Indeed, most cardiovascular risk factors are associated with inflammation.28 Microvascular spasm may also be related to cardiovascular risk factors and low-grade inflammation.

Genetic Factors Several genetic polymorphisms have been described as potentially involved in the predisposition for coronary spasm. Most of these mutations concern the gene encoding for NO synthase,29,30 but mutations in other mole-

own contraction, and resultant medial thickening and folding of the internal elastic lamina create a piston effect to narrow the lumen19 (Figure 3). The molecular pathways leading to spasm are still not fully understood, but the rho-kinase path-way has emerged as important in the genesis of spasm.17

Autonomic Nervous System The relationship between the autonomic nervous system and coronary spasm is complex. An increase in both the sympathetic and parasympathetic tone is able to induce coronary spasm.14 An increase in sympathetic activity may cause coronary spasm through an increase in noradrenaline, the neurotransmitter of efferent sympathetic fibers, causing vasoconstriction by stimulating VSMCs. Ace-tylcholine, the neurotransmitter in the parasympathetic nerve fibers, causes vasodilation in normal vessels at low dosage but may also cause vasoconstriction by stimulating VSMCs. As the parasympathetic innervation derives from the adventitia of the vessel, alterations in neuronal nitric oxide (NO) synthase may play an important role in this setting, as shown by Seddon et al.20

Endothelial Dysfunction The endothelium has a very important role in the regulation of coronary vascular tone, predominantly through its ability to release several vasodila-tors, with NO being the most important.14 Endothelial dys-function with abnormalities in NO release and its reduced bioavailability combined with hyperreactivity of VSMCs may be an important factor in developing coronary spasm. How-ever, it is important to remember that endothelial dysfunction alone is not sufficient to explain the phenomenon of coronary spasm because it requires the activation of VSMCs.

Figure 3. Schematic presentation of structural changes in the spastic coronary arterial wall. (A) Connection patterns of SMCs to the IEL in the non-spastic state. (B) Connection patterns of SMCs and their direction patterns during spasm. (C) Pattern of SMCs connecting the IEL to the external elastic lamina (EEL) in the non-spastic state. (D) Re-arranged pattern of SMCs connecting the IEL to the EEL in the spastic state. (a and b indicate the connection points to the IEL and EEL, respectively.) Contraction of SMCs reduces the distance between a and b, with resultant radial rearrangement of SMCs, leading to folding of the IEL, gathering of the EEL, medial thickening and luminal narrowing. I, intima. (Reproduced with permission from Uchida Y, et al.19)


1434 ONG P et al.

and it is conceivable that some risk factors cause structural changes leading to permanent damage of the microcirculation. In hypertension, for example, intima thickening and perivas-cular fibrosis are often seen (Figure 4),40 the latter impairing the microvasculature’s ability to dilate independently of VSMC function. An inflammatory milieu may lead to structural changes and enhance the tendency of the microcirculation to spasm. However, the exact triggers leading to a clinical presentation of coronary (microvascular) spasm are still poorly understood. Current pathophysiological concepts of coronary microvascu-lar dysfunction have recently been reviewed elsewhere.41

Epicardial ArteriesAs mentioned earlier, coronary spasm can occur in patients with normal coronary arteries as well as in patients with ath-erosclerosis. Moreover, percutaneous coronary intervention can be associated with coronary spasm.42 However, it is still poorly understood whether coronary spasm can promote ath-erosclerotic alterations or whether the latter may predispose to spasm. There are several reports of structural alterations of the epicardial arteries in patients with vasospastic angina. These may be visualized invasively by coronary angiography, IVUS and OCT and non-invasively by CTA.

Coronary AngiographyIn some patients coronary spasm may be superimposed on an atherosclerotic lesion and it is conceivable that repetitive spasm in the area of such a lesion may lead to plaque rupture and acute myocardial infarction.43 It is often difficult to assess the interplay of the structural and functional aspects of sig-nificant epicardial stenosis because intracoronary provocation testing for the assessment of coronary spasm is usually not performed in the presence of a relevant stenosis. However, occasionally, spontaneous attacks of epicardial spasm can be observed during diagnostic coronary angiography, illustrating the role of coronary spasm superimposed on a relevant coro-nary stenosis. In such cases it may be useful to perform percu-taneous coronary intervention to reduce the tendency of the vessel to spasm (Figure 5).44

Coronary Computed Tomographic AngiographyCTA is useful for the detection of coronary artery calcium burden, as well as for the detection of relevant epicardial ste-nosis.45 Several reports have highlighted the usefulness of CTA in the evaluation of patients with vasospastic angina. In some cases, CTA showed a relevant stenosis that was later

cules responsible for modulation of vascular tone have also been suggested.31,32 It should however be mentioned that nearly all these studies have been performed in Asian patients and only recently a study in Italian patients has described genetic polymorphisms associated with coronary microvascu-lar dysfunction.33

Functional ChangesAs mentioned, coronary spasm is a phenomenon that involves the sudden and transient vasoconstriction of a coronary blood vessel because of vascular smooth muscle hyperreactivity caused by various factors. The number of affected vessels, as well as the location of the spasm, may vary34 and after resolu-tion of spasm the vessel diameter usually returns to the previ-ous size. These functional changes can occur in patients with epicardially normal arteries, as well as in those with athero-sclerotic plaques or even relevant stenosis (see later) and may also affect the microvessels. Depending on the severity, the duration and frequency coronary spasm can lead to myocar-dial ischemia and may also cause permanent damage to the vascular wall. Such structural alterations can be visualized using intracoronary imaging techniques such as IVUS or OCT. Microvascular changes cannot be visualized in vivo at the moment, but non-invasive techniques such as PET or myocardial contrast echocardiography during invasive vaso-motor studies can provide indirect information about micro-vascular function.35,36

Experimentally, various triggers have been identified to elicit coronary spasm, such as serotonin, thromboxane, histamine37 and acetylcholine (ACh). The latter is, together with ergono-vine, frequently used for intracoronary provocation testing for coronary spasm in the clinical setting.38 Apart from occasional documentation of coronary spasm on computed tomography (see later), intracoronary provocation testing is currently the only possible method of visualizing coronary spasms system-atically in humans.

Structural ChangesMicrocirculationEarly changes in or damage to the coronary vasculature in response to cardiovascular risk factors can affect the microcir-culation as well as the epicardial arteries.36,39 It is well known that cardiovascular risk factors are associated with vascular inflammation, which may lead to impaired microcirculation28

Figure 4. Normal vascular wall thickness of the microvessels in a normotensive patient (Left) and increased vascular wall thick-ness, perivascular fibrosis, proliferation of the intima in a hypertensive patient (Right). (Reproduced with permission from Schannwell CM, et al.40)



spastic coronary artery in patients with positive ACh test had a diffuse thickened intima in the entire artery compared with an age- and sex-matched control group with atypical chest pain and negative ACh test. The plaque composition, how-ever, in the 2 groups was identical.56 These findings under-score the fact that focal coronary spasm is associated with epicardial atherosclerosis. Our own experience is that stenotic lesions with superimposed spasm are uniformly eccentric with a free arc of normal-appearing coronary wall. Spasm occurs by contraction of the portion of the wall unaffected by the eccentric plaque.

Optical Coherence TomographyIn an early study from Morikawa et al using OCT in patients with vasospastic angina the coronary artery segments involved in spasm were characterized by diffuse intimal thickening without lipid or calcium content,57 findings similar to those reported from IVUS-based studies.53,55 Tanaka et al described patients with vasospastic angina as having a larger media thickness, intimal bump at rest and intimal gathering during spasm58 (Figure 6). Moreover, Park et al showed that in patients with vasospasm-induced acute coronary syndrome, intimal tear, intimal erosion, and microthrombi are major abnormal morphologic findings of OCT compared with patients with chronic stable variant angina.59

Overall, intracoronary imaging techniques have shown that focal coronary spasm is associated with non-calcified epicar-dial lesions. Moreover, both intimal and media thickening are

confirmed as coronary spasm on invasive angiography.46,47 Conversely, CTA clearly ruled out left main stem stenosis that had been seen on invasive angiography and was most likely catheter-induced spasm.48 Analysis of coronary plaque mor-phology in Japanese patients with vasospastic angina using CTA has shown that atherosclerotic plaques without sig-nificant luminal narrowing in areas of inducible vasospasm compared with areas without vasospasm were more often non-calcified with negative remodeling.49 Similar results were obtained in a Korean study of vasospastic angina patients in whom negative remodeling but no definite evidence of plaque was seen on CT in areas of focal coronary spasm.50

Intravascular UltrasoundIVUS is a useful technology to evaluate coronary plaques in vivo.51 Combined with virtual histology (VH-IVUS), it is pos-sible to study the plaque composition in an epicardial artery.52 Early studies in patients with vasospastic angina and angio-graphically normal coronary arteries have shown that spastic arteries show significant intimal thickening.53 Hong et al reported the IVUS findings of patients with focal coronary spasm, showing atherosclerotic lesions at all coronary spasm sites with a high incidence of negative arterial remodeling54 compared with proximal and distal sites. Similar results were shown by Saito et al in a Japanese IVUS study in which patients with focal spasm had atherosclerotic lesions in 100% of cases but calcification of the lesions was uncommon.55 A Japanese VH-IVUS study from 2013 showed that the vaso-

Figure 5. Spontaneous occlusion of the right coronary artery with inferior ST-segment elevation (A). Visualization of a relevant stenosis in the right coronary artery after nitroglycerin injection (B). Acetylcholine-induced occlusive epicardial spasm with repro-duction of the patient’s symptoms and inferior ST-segment elevation after 80 µg ACh (C) and (D) no inducible spasm after stent implantation in the right coronary artery and repeated ACh provocation testing (stent in brackets). (Reproduced from Bentz K, et al.44)


1436 ONG P et al.

thin-cap fibroatheroma),63 but these results need further con-firmation as data from large follow-up studies are lacking.

Racial DifferencesIt has been suggested that coronary spasm is more prevalent among Asians than in white populations,64 but our prior eval-uation of 921 consecutive white patients with angina pectoris and unobstructed coronary arteries showed epicardial or microvascular spasm in a similarly high proportion of 57% of the patients.61 This has been supported by previous studies of European patients showing a similar frequency of coronary spasm compared with Japanese studies.65,66 These findings indicate that coronary artery spasm may play an important role in angina pectoris patients without significant differences between ethnic groups.

ConclusionsPatients with vasospastic angina represent a heterogeneous cohort of patients with regard to the extent of concomitant coronary atherosclerosis. They share the common pathophys-iological phenomenon of VSMC hyperreactivity leading to spasm caused by various factors that may also overlap. Focal coronary spasm is related to epicardial atherosclerosis and in the presence of obstructive coronary artery disease it may be useful to treat the lesion to prevent further spasm. Investiga-

frequently found in patients with vasospastic angina.

Knowledge GapsSexIn the USA, functional coronary vasomotor abnormalities have been studied most often in women, with a focus on microvas-cular dysfunction, whereas in Asia, especially in Japan, coro-nary artery spasm is a male disease with an epicardial location. Recently, reports from Japan have highlighted sex differences among patients with vasospastic angina60 and we have reported that coronary microvascular spasm is indeed more prevalent in German women and epicardial spasm is more prevalent in German men.61 This underscores the need for further investi-gations on sex differences in patients with vasospastic angina.

Relationship Between Epicardial and Microvascular Disorders The relationship between epicardial and microvascular vaso-motor abnormalities is poorly understood. Clinical observa-tions suggest that a subgroup of patients may have a common pathophysiological background leading to microvascular dys-function at low doses of ACh provocation and epicardial spasm at higher doses.62 Moreover, some studies have sug-gested that patients with coronary microvascular dysfunction have increased epicardial plaque vulnerability on IVUS (ie,

Figure 6. Representative optical coherence tomography (OCT) images of a spastic lesion (A–C) and a non-spastic lesion (D–F). (A) Intimal bumps that deform the lumen and a thickened medial layer can be seen. (B) During provocation testing for coronary spasm, medial thickness increases, causing luminal narrowing with intimal gathering. Medial thickness is 0.38 mm (double-headed arrow). (C) Both intimal bumps and gathering have disappeared. (D–F) No obvious morphological change can be seen in the non-spastic lesion throughout the provocation test. NTG, nitroglycerine. (Reproduced with permission from Tanaka A, et al.58)



20. Seddon M, Melikian N, Dworakowski R, Shabeeh H, Jiang B, Byrne J, et al. Effects of neuronal nitric oxide synthase on human coronary artery diameter and blood flow in vivo. Circulation 2009; 119: 2656 – 2962.

21. Miyamoto S, Kawano H, Sakamoto T, Soejima H, Kajiwara I, Hokamaki J, et al. Increased plasma levels of thioredoxin in patients with coronary spastic angina. Antioxid Redox Signal 2004; 6: 75 – 80.

22. Miwa K, Miyagi Y, Igawa A, Nakagawa K, Inoue H. Vitamin E deficiency in variant angina. Circulation 1996; 94: 14 – 18.

23. Hung MJ, Cherng WJ, Cheng CW, Li LF. Comparison of serum levels of inflammatory markers in patients with coronary vasospasm without significant fixed coronary artery disease versus patients with stable angina pectoris and acute coronary syndromes with significant fixed coronary artery disease. Am J Cardiol 2006; 97: 1429 – 1434.

24. Itoh T, Mizuno Y, Harada E, Yoshimura M, Ogawa H, Yasue H. Coronary spasm is associated with chronic low-grade inflammation. Circ J 2007; 71: 1074 – 1078.

25. Ong P, Carro A, Athanasiadis A, Borgulya G, Schäufele T, Ratge D, et al. Acetylcholine-induced coronary spasm in patients with unob-structed coronary arteries is associated with elevated concentrations of soluble CD40 ligand and high-sensitivity C-reactive protein. Coron Artery Dis 2015; 26: 126 – 132.

26. Hiroki J, Shimokawa H, Higashi M, Morikawa K, Kandabashi T, Kawamura N, et al. Inflammatory stimuli upregulate Rho-kinase in human coronary vascular smooth muscle cells. J Mol Cell Cardiol 2004; 37: 537 – 546.

27. Hung MY, Hsu KH, Hung MJ, Cheng CW, Kuo LT, Cherng WJ. Interaction between cigarette smoking and high-sensitivity C-reac-tive protein in the development of coronary vasospasm in patients without hemodynamically significant coronary artery disease. Am J Med Sci 2009; 338: 440 – 446.

28. Granger DN, Rodrigues SF, Yildirim A, Senchenkova EY. Micro-vascular responses to cardiovascular risk factors. Microcirculation 2010; 17: 192 – 205.

29. Nakayama M, Yasue H, Yoshimura M, Shimasaki Y, Kugiyama K, Ogawa H, et al. T-786-->C mutation in the 5’-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 1999; 99: 2864 – 2870.

30. Chang K, Baek SH, Seung KB, Kim PJ, Ihm SH, Chae JS, et al. The Glu298Asp polymorphism in the endothelial nitric oxide synthase gene is strongly associated with coronary spasm. Coron Artery Dis 2003; 14: 293 – 299.

31. Yoo SY, Kim J, Cheong S, Shin DH, Jang J, Lee C, et al. Rho-associated kinase 2 polymorphism in patients with vasospastic angina. Korean Circ J 2012; 42: 406 – 413.

32. Honda T, Sugiyama S, Sakamoto T, Kaikita K, Ogawa H. Impact of delta-sarcoglycan gene polymorphism on the occurrence of coronary spastic angina in Japanese patients with hypertrophic cardiomyopa-thy. Circ J 2007; 71: 1263 – 1267.

33. Fedele F, Mancone M, Chilian WM, Severino P, Canali E, Logan S, et al. Role of genetic polymorphisms of ion channels in the patho-physiology of coronary microvascular dysfunction and ischemic heart disease. Basic Res Cardiol 2013; 108: 387.

34. Ozaki Y, Keane D, Serruys PW. Fluctuation of spastic location in patients with vasospastic angina: A quantitative angiographic study. J Am Coll Cardiol 1995; 26: 1606 – 1614.

35. Arrebola-Moreno AL, Arrebola JP, Moral-Ruiz A, Ramirez-Hernandez JA, Melgares-Moreno R, Kaski JC. Coronary microvascular spasm triggers transient ischemic left ventricular diastolic abnormalities in patients with chest pain and angiographically normal coronary arter-ies. Atherosclerosis 2014; 236: 207 – 214.

36. Camici PG, d’Amati G, Rimoldi O. Coronary microvascular dys-function: Mechanisms and functional assessment. Nat Rev Cardiol 2015; 12: 48 – 62.

37. Shimokawa H, Tomoike H, Nabeyama S, Yamamoto H, Ishii Y, Tanaka K, et al. Coronary artery spasm induced in miniature swine: Angiographic evidence and relation to coronary atherosclerosis. Am Heart J 1985; 110: 300 – 310.

38. Ong P, Athanasiadis A, Sechtem U. Patterns of coronary vasomotor responses to intracoronary acetylcholine provocation. Heart 2013; 99: 1288 – 1295.

39. Rubinshtein R, Yang EH, Rihal CS, Prasad A, Lennon RJ, Best PJ, et al. Coronary microcirculatory vasodilator function in relation to risk factors among patients without obstructive coronary disease and low to intermediate Framingham score. Eur Heart J 2010; 31: 936 – 942.

40. Schannwell CM, Steiner S, Strauer BE. Hypertensive microvascular disease. Herz 2005; 30: 26 – 36 (in German).

41. Crea F, Camici PG, Bairey Merz CN. Coronary microvascular dys-function: An update. Eur Heart J 2014; 35: 1101 – 1111.

tions in patients with unexplained chest pain should not only integrate fractional flow reserve, OCT and IVUS if indicated,67 but should also incorporate assessment of functional vasomo-tor disorders using, for example, intracoronary provocation testing for the detection of coronary spasm.

DisclosuresNo conflicts to disclose.

References 1. Prinzmetal M, Kennamer R, Merliss R, Wada T, Bor N. Angina

pectoris. I: A variant form of angina pectoris: Preliminary report. Am J Med 1959; 27: 375 – 388.

2. Cheng TO, Bashour T, Kelser GA Jr, Weiss L, Bacos J. Variant angina of Prinzmetal with normal coronary arteriograms: A variant of the variant. Circulation 1973; 47: 476 – 485.

3. Oliva PB, Potts DE, Pluss RG. Coronary arterial spasm in Prinzmetal angina: Documentation by coronary arteriography. N Engl J Med 1973; 288: 745 – 751.

4. Mohri M, Koyanagi M, Egashira K, Tagawa H, Ichiki T, Shimokawa H, et al. Angina pectoris caused by coronary microvascular spasm. Lancet 1998; 351: 1165 – 1169.

5. Hung MJ, Hu P, Hung MY. Coronary artery spasm: Review and update. Int J Med Sci 2014; 11: 1161 – 1171.

6. JCS Joint Working Group. Guidelines for diagnosis and treatment of patients with vasospastic angina (Coronary Spastic Angina) (JCS 2013): Digest version. Circ J 2014; 78: 2779 – 2801.

7. Ong P, Athanasiadis A, Mahrholdt H, Shah BN, Sechtem U, Senior R. Transient myocardial ischemia during acetylcholine-induced coronary microvascular dysfunction documented by myocardial con-trast echocardiography. Circ Cardiovasc Imaging 2013; 6: 153 – 155.

8. Infusino F, Lanza GA, Sestito A, Sgueglia GA, Crea F, Maseri A. Combination of variant and microvascular angina. Clin Cardiol 2009; 32: E40 – E45.

9. Austen WG, Edwards JE, Frye RL, Gensini GG, Gott VL, Griffith LS, et al. A reporting system on patients evaluated for coronary artery disease: Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 1975; 51(Suppl): 5 – 40.

10. Bertrand ME, LaBlanche JM, Tilmant PY, Thieuleux FA, Delforge MR, Carre AG, et al. Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography. Circulation 1982; 65: 1299 – 1306.

11. Myerburg RJ, Kessler KM, Mallon SM, Cox MM, deMarchena E, Interian A Jr, et al. Life-threatening ventricular arrhythmias in patients with silent myocardial ischemia due to coronary-artery spasm. N Engl J Med 1992; 326: 1451 – 1455.

12. Yasue H, Omote S, Takizawa A, Nagao M, Miwa K, Tanaka S. Circadian variation of exercise capacity in patients with Prinzmetal’s variant angina: Role of exercise-induced coronary arterial spasm. Circulation 1979; 59: 938 – 948.

13. Igarashi Y, Yamazoe M, Suzuki K, Tamura Y, Matsubara T, Tanabe Y, et al. Possible role of coronary artery spasm in unexplained syn-cope. Am J Cardiol 1990; 65: 713 – 717.

14. Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, et al. 2013 ESC Guidelines on the Management of Stable Coronary Artery Disease: The Task Force on the Management of Stable Coronary Artery Disease of the European Society of Cardiol-ogy. Eur Heart J 2013; 34: 2949 – 3003.

15. Sato K, Kaikita K, Nakayama N, Horio E, Yoshimura H, Ono T, et al. Coronary vasomotor response to intracoronary acetylcholine injection, clinical features, and long-term prognosis in 873 consecu-tive patients with coronary spasm: Analysis of a single-center study over 20 years. J Am Heart Assoc 2013; 2: e000227, doi:10.1161/JAHA.113.000227.

16. Lanza GA, Careri G, Crea F. Mechanisms of coronary artery spasm. Circulation 2011; 124: 1774 – 1782.

17. Shimokawa H. Cellular and molecular mechanisms of coronary artery spasm: Lessons from animal models. Jpn Circ J 2000; 64: 1 – 12.

18. Gross L, Epstein EZ, Kugel MA. Histology of the coronary arteries and their branches in the human heart. Am J Pathol 1934; 10: 253 – 274.

19. Uchida Y, Uchida Y, Matsuyama A, Koga A, Maezawa Y, Maezawa Y, et al. Functional medial thickening and folding of the internal elastic lamina in coronary spasm. Am J Physiol Heart Circ Physiol 2011; 300: H423 – H430.


1438 ONG P et al.

angina: Study using intravascular ultrasound. Circ J 2003; 67: 1041 – 1045.

56. Tsujita K, Sakamoto K, Kojima S, Kojima S, Takaoka N, Nagayoshi Y, et al. Coronary plaque component in patients with vasospastic angina: A virtual histology intravascular ultrasound study. Int J Cardiol 2013; 168: 2411 – 2415.

57. Morikawa Y, Uemura S, Ishigami K, Soeda T, Okayama S, Takemoto Y, et al. Morphological features of coronary arteries in patients with coronary spastic angina: Assessment with intracoronary optical coherence tomography. Int J Cardiol 2011; 146: 334 – 340.

58. Tanaka A, Shimada K, Tearney GJ, Kitabata H, Taguchi H, Fukuda S, et al. Conformational change in coronary artery structure assessed by optical coherence tomography in patients with vasospastic angina. J Am Coll Cardiol 2011; 58: 1608 – 1613.

59. Park HC, Shin JH, Jeong WK, Choi SI, Kim SG. Comparison of morphologic findings obtained by optical coherence tomography in acute coronary syndrome caused by vasospasm and chronic stable variant angina. Int J Cardiovasc Imaging 2015; 31: 229 – 237.

60. Kawana A, Takahashi J, Takagi Y, Yasuda S, Sakata Y, Tsunoda R, et al; Japanese Coronary Spasm Association. Gender differences in the clinical characteristics and outcomes of patients with vasospastic angina: A report from the Japanese Coronary Spasm Association. Circ J 2013; 77: 1267 – 1274.

61. Ong P, Athanasiadis A, Borgulya G, Vokshi I, Bastiaenen R, Kubik S, et al. Clinical usefulness, angiographic characteristics, and safety evaluation of intracoronary acetylcholine provocation testing among 921 consecutive white patients with unobstructed coronary arteries. Circulation 2014; 129: 1723 – 1730.

62. Sun H, Mohri M, Shimokawa H, Usui M, Urakami L, Takeshita A. Coronary microvascular spasm causes myocardial ischemia in patients with vasospastic angina. J Am Coll Cardiol 2002; 39: 847 – 851.

63. Dhawan SS, Corban MT, Nanjundappa RA, Eshtehardi P, McDaniel MC, Kwarteng CA, et al. Coronary microvascular dysfunction is associated with higher frequency of thin-cap fibroatheroma. Athero-sclerosis 2012; 223: 384 – 388.

64. Beltrame JF, Sasayama S, Maseri A. Racial heterogeneity in coro-nary artery vasomotor reactivity: Differences between Japanese and Caucasian patients. J Am Coll Cardiol 1999; 33: 1442 – 1452.

65. Coma-Canella I, Castano S, Macías A, Calabuig J, Artaiz M. Ergo-novine test in angina with normal coronary arteries: Is it worth doing it? Int J Cardiol 2006; 107: 200 – 206.

66. Sueda S, Ochi N, Kawada H, Matsuda S, Hayashi Y, Tsuruoka T, et al. Frequency of provoked coronary vasospasm in patients undergo-ing coronary arteriography with spasm provocation test of acetylcho-line. Am J Cardiol 1999; 83: 1186 – 1190.

67. Shiono Y, Kubo T, Tanaka A, Ino Y, Yamaguchi T, Tanimoto T, et al. Long-term outcome after deferral of revascularization in patients with intermediate coronary stenosis and gray-zone fractional flow reserve. Circ J 2015; 79: 91 – 95.

42. Ong P, Athanasiadis A, Perne A, Mahrholdt H, Schäufele T, Hill S, et al. Coronary vasomotor abnormalities in patients with stable angina after successful stent implantation but without in-stent reste-nosis. Clin Res Cardiol 2014; 103: 11 – 19.

43. Kuga T, Tagawa H, Tomoike H, Mitsuoka W, Egashira S, Ohara Y, et al. Role of coronary artery spasm in progression of organic coro-nary stenosis and acute myocardial infarction in a swine model: Importance of mode of onset and duration of coronary artery spasm. Circulation 1993; 87: 573 – 582.

44. Bentz K, Ong P, Sechtem U. Unstable angina pectoris: Combination of an epicardial stenosis and a Prinzmetal spasm. Dtsch Med Wochenschr 2013; 138: 2546 – 2549 (in German).

45. Kawai H, Motoyama S, Sarai M, Ito H, Takahashi H, Harigaya H, et al. Adding coronary computed tomography angiography to invasive coronary angiography improves prediction of cardiac events. Circ J 2014; 78: 2735 – 2740.

46. Ota M, Anan I, Morimoto S, Minai K, Komukai K, Ogawa T, et al. Severe lasting coronary spasm detected by multi-detector row com-puted tomography. Int J Cardiol 2011; 153: e62 – e64, doi:10.1016/j.ijcard.2011.02.062.

47. Ito K, Ogawa T, Yoshimura M. Severe coronary spasm occasionally detected by coronary computed tomography. Eur Heart J 2009; 30: 2768.

48. Pflederer T, Marwan M, Ropers D, Daniel WG, Achenbach S. CT angiography unmasking catheter-induced spasm as a reason for left main coronary artery stenosis. J Cardiovasc Comput Tomogr 2008; 2: 406 – 407.

49. Ito T, Terashima M, Kaneda H, Nasu K, Ehara M, Kinoshita Y, et al. In vivo assessment of ergonovine-induced coronary artery spasm by 64-slice multislice computed tomography. Circ Cardiovasc Imaging 2012; 5: 226 – 232.

50. Kang KM, Choi SI, Chun EJ, Kim JA, Youn TJ, Choi DJ. Coronary vasospastic angina: Assessment by multidetector CT coronary angi-ography. Korean J Radiol 2012; 13: 27 – 33.

51. Peters RJ, Kok WE, Havenith MG, Rijsterborgh H, van der Wal AC, Visser CA. Histopathologic validation of intracoronary ultrasound imaging. J Am Soc Echocardiogr 1994; 7: 230 – 241.

52. Nair A, Kuban BD, Tuzcu EM, Schoenhagen P, Nissen SE, Vince DG. Coronary plaque classification with intravascular ultrasound radiofrequency data analysis. Circulation 2002; 106: 2200 – 2206.

53. Miyao Y, Kugiyama K, Kawano H, Motoyama T, Ogawa H, Yoshimura M, et al. Diffuse intimal thickening of coronary arteries in patients with coronary spastic angina. J Am Coll Cardiol 2000; 36: 432 – 437.

54. Hong MK, Park SW, Lee CW, Ko JY, Kang DH, Song JK, et al. Intravascular ultrasound findings of negative arterial remodeling at sites of focal coronary spasm in patients with vasospastic angina. Am Heart J 2000; 140: 395 – 401.

55. Saito S, Yamagishi M, Takayama T, Chiku M, Koyama J, Ito K, et al. Plaque morphology at coronary sites with focal spasm in variant

structural and functional coronary artery abnormalities in

Documents